Italy's biotech sector may have lagged that of other developed countries but change may be afoot as European venture capital firm Sofinnova Partners has launched the country's first biotech accelerator.
Italy's biotech sector may have lagged that of other developed countries but change may be afoot as European venture capital firm Sofinnova Partners has launched the country's first biotech accelerator.
Known as BiovelocITA, the accelerator aims to advance research projects that have a strong scientific basis to a proof-of-concept stage...
The big pharma CEO with the highest-valued compensation in 2024 was David Ricks of Eli Lilly, while Pfizer and J&J executives slipped into third and fourth place behind AbbVie's now retired chief Richard Gonzalez. European firms brought up the rear.
The FDA has paused Gilead’s HIV trials of GS-1720 and GS-4182 over safety concerns. The company’s upcoming PrEP PDUFA looks to be unaffected.
Merck and Lilly are among the leading pharma players using space-based research to power drug development. From reusable satellites to process drugs in low earth orbit to biomanufacturing labs experts discuss R&D opportunities in the starry canvas above.
